A US FDA advisory panel has voted narrowly to allow compounding pharmacies to produce several peptides that currently sit outside approval, including BPC-157, TB-500 and KPV
How CagriSema Compares With Current GLP-1 Medications One of the biggest questions people have is how CagriSema compares with medications such as Wegovy, Zepbound, or Mounjaro
The practical implications of this difference extend to manufacturing, patent protection, dosing flexibility, and potentially even clinical outcomes
Energy Environ
In adults, restoring ferritin to the 70100 ng/mL range is associated with measurable improvements in energy, mood, and exercise capacity within 812 weeks
If you prescribe peptides right now, the patient conversation is moving faster than the legal infrastructure